ALMKT Share Price Performance
€0.10
-0.27 (-72.65%)
Price €0.10
Share Price€0.10
ALMKT Community Narratives
There are no narratives available yet.
Recent ALMKT News & Updates
No updates
Mauna Kea Technologies SA Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
Oct 02, 2025
- Earnings per share (EPS)
- -0.13
- Gross Margin
- 85.78%
- Net Profit Margin
- -123.64%
- Debt/Equity Ratio
- -126.1%
Mauna Kea Technologies SA Competitors
About ALMKT
- Founded
- 2000
- Employees
- 65
- CEO
- WebsiteView website
Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally. It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions. The company was incorporated in 2000 and is headquartered in Paris, France.
French Market Performance
- 7 Days: -3.8%
- 3 Months: -2.7%
- 1 Year: 3.7%
- Year to Date: 0.7%
Over the last 7 days, the market has dropped 3.9%, driven by a decline of 7.9% in the Consumer Discretionary sector. Although the market performance has been flat over the past year. As for the next few years, earnings are expected to grow by 12% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading